Examination of the psychometric properties of pediatric-modified total neuropathy score in Turkish children with cancer.

Creative Commons License

Özdemir B., Gerçeker G., Özdemir E. Z., Yıldırım B. G., Ören H., Yiş U., ...More

Journal of pediatric nursing, vol.69, pp.31-37, 2023 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 69
  • Publication Date: 2023
  • Doi Number: 10.1016/j.pedn.2022.12.017
  • Journal Name: Journal of pediatric nursing
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus, ASSIA, CINAHL, MEDLINE, DIALNET
  • Page Numbers: pp.31-37
  • Dokuz Eylül University Affiliated: Yes


Background: Evaluation of chemotherapy-induced peripheral neuropathy has gained importance in symptom management of pediatric patients with cancer. This study aimed to perform the Turkish validity and reliability study of the Pediatric-Modified Total Neuropathy Score (Ped-mTNS). Methods: A methodological, descriptive, and cross-sectional design was used in the study. Forty children aged between 5 and 18 and were treated for cancer and 40 age- and gender-matched healthy children (control group) were included in the study. The mean scores of the items on the Ped-mTNS were compared, and itemtotal score correlationswere evaluated. Cronbach's alpha coefficient of the Ped-mTNS was calculated for internal consistency. Findings: Cronbach's alpha value of the scale was found as 0.709. The item-total correlations of the scale items ranged from 0.260 to 0.658. The mean score of cancer patients on the Ped-mTNS was found as 4.4 +/- 3.8. Discussion: Ped-mTNS scores of children with cancer indicated more deficits than those of the control group. In the evaluation of children in the patient and control groups, a difference was found in terms of light touch sensation, which is one of the sensory symptoms in the items of the Ped-mTNS, and pin sensibility and strength, which are among the clinical symptoms. Application to practice: The Ped-mTNS was determined to be a valid and reliable measurement tool for children with cancer aged between 5 and 18 in the Turkish population. (c) 2022 Elsevier Inc. All rights reserved.